Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning
Go back to Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning| (NASDAQ: HTFL) | Delayed: 27.97 -2.74 (8.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.71 | 52 Week High | $ | |||
| Open | $30.93 | 52 Week Low | $ | |||
| Day High | $30.98 | P/E | N/A | |||
| Day Low | $27.63 | EPS | $ | |||
| Volume | 1,892,462 | |||||
